XML 28 R18.htm IDEA: XBRL DOCUMENT
v3.23.3

Accrued Liabilities, Commitments and Contingencies | 9 Months Ended
--- | ---
Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract] |
Accrued Liabilities, Commitments and Contingencies | Accrued Liabilities, Commitments and Contingencies Accrued Liabilities The components of Accrued liabilities are as follows (in millions):
| September 30, 2023 |  | December 31, 2022
Settlement | $ | 90 |  |  | $ | 180 |
Payroll and benefits | 84 |  |  | 90 |
Unremitted cash collections due to banks on factored accounts receivable | 82 |  |  | 130 |
Exit and restructuring | 54 |  |  | 9 |
Customer rebates | 38 |  |  | 55 |
Current portion of lease liabilities | 38 |  |  | 37 |
Incentive compensation | 31 |  |  | 100 |
Warranty | 25 |  |  | 26 |
Freight and duty | 10 |  |  | 19 |
Foreign exchange contracts | — |  |  | 19 |
Other | 76 |  |  | 79 |
Accrued liabilities | $ | 528 |  |  | $ | 744 |
Warranties The following table is a summary of the Company’s accrued warranty obligations (in millions):
| Nine Months Ended
| September 30, 2023 |  | October 1, 2022
Balance at the beginning of the period | $ | 26 |  |  | $ | 26 |
Warranty expense | 21 |  |  | 23 |
Warranties fulfilled | (22) |  |  | (22) |
Balance at the end of the period | $ | 25 |  |  | $ | 27 |
Contingencies The Company is subject to a variety of investigations, claims, suits, and other legal proceedings that arise from time to time in the ordinary course of business, including but not limited to, intellectual property, employment, tort, and breach of contract matters. The Company currently believes that the outcomes of such proceedings, individually and in the aggregate, will not have a material adverse impact on its business, cash flows, financial position, or results of operations. Any legal proceedings are subject to inherent uncertainties, and the Company’s view of these matters and their potential effects may change in the future. The Company records a liability for contingencies when a loss is deemed to be probable and can be reasonably estimated. During the second quarter of 2022, the Company entered into a License and Settlement Agreement (“Settlement”) to resolve certain patent-related litigation. The payment terms under the Settlement consist of 8 quarterly payments of $45 million that began in the second quarter of 2022. The remaining 2 quarterly amounts will be paid by the first quarter of 2024 and are included within Accrued liabilities on the Consolidated Balance Sheets.

X
- References No definition available. + Details
Name: | us-gaap_CommitmentsAndContingenciesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Accrued Liabilities, Commitments and Contingencies + References No definition available. + Details
Name: | zbra_AccruedLiabilitiesCommitmentsAndContingenciesTextBlock
Namespace Prefix: | zbra_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration